Arginine treatment for children’s sickle cell pain
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This early-phase study tests whether arginine can help control pain in children with sickle cell disease. You may be considered if your child is having a sickle cell pain episode that needs stronger pain medicine given through an IV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has sickle cell disease type Hb-SS or Hb S beta-zero thalassemia
- Your child is 7 to 21 years old
- Your child weighs at least 25 kg (55 pounds)
- They are having a pain episode that needs medical care right now and IV (through a vein) opioid pain medicine
- There are no exclusions like recent use of arginine or certain other medicines in the last 14 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
This Phase 1 study tests whether nicotinamide, oral tetrahydrouridine, and decitabine can help people with high-risk sickle cell disease. It is mainly a safety-and-dosing study, but it also looks for signs the medicines may improve disease-related problems.
This study tests an experimental gene therapy called CS-206 for teenagers with sickle cell disease. It aims to help reduce severe complications by modifying the patient's own blood stem cells.
This trial tests if cannabidiol (CBD) can help reduce pain interference in adults with sickle cell disease. You will take CBD daily for 4 weeks and report your pain levels.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.